Zhang Jun-hua, Zhu Yan, Fan Xiao-hui, Zhang Bo-li
Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Pharmaceutical Informatics Institute, Zhejiang University, Hangzhou 310058, China.
Acta Pharmacol Sin. 2015 Jun;36(6):654-8. doi: 10.1038/aps.2015.8. Epub 2015 Apr 13.
Single-target drugs have not achieved satisfactory therapeutic effects for complex diseases involving multiple factors. Instead, innovations in recent drug research and development have revealed the emergence of compound drugs, such as cocktail therapies and "polypills", as the frontier in new drug development. A traditional Chinese medicine (TCM) prescription that is usually composed of several medicinal herbs can serve a typical representative of compound medicines. Although the traditional compatibility theory of TCM cannot be well expressed using modern scientific language nowadays, the fundamental purpose of TCM compatibility can be understood as promoting efficacy and reducing toxicity. This paper introduces the theory and methods of efficacy-oriented compatibility for developing component-based Chinese medicines.
对于涉及多种因素的复杂疾病，单靶点药物尚未取得令人满意的治疗效果。相反，近年来药物研发的创新表明，复方药物如鸡尾酒疗法和“多效药丸”的出现，成为新药研发的前沿。通常由几种草药组成的中药方剂就是复方药物的典型代表。尽管如今中医传统配伍理论难以用现代科学语言充分表述，但中医配伍的根本目的可理解为增效减毒。本文介绍了基于组效关系研发中药组分药物的理论与方法。
